习惯性咖啡、茶和咖啡因摄入、循环代谢物与心脏代谢多病风险
基于英国生物银行172315名(咖啡因分析)和188091名(茶与咖啡分析)基线无心脏代谢疾病参与者的前瞻性研究,发现咖啡、茶和咖啡因摄入与新发心脏代谢多病风险呈非线性负相关;适量咖啡(3杯/天)或咖啡因(200-300毫克/天)者风险最低,风险比分别为0.519(95%CI 0.417-0.647)和0.593(95%CI 0.499-0.704);80至97种代谢物与摄入及新发心脏代谢多病相关。
要点
- 适量咖啡(3杯/天)或咖啡因(200-300毫克/天)摄入与新发心脏代谢多病风险最低相关。
- 咖啡或咖啡因摄入与心脏代谢多病几乎全部发展阶段的转换风险呈负相关。
- 80至97种代谢物(如极低密度脂蛋白脂质成分、组氨酸、糖蛋白乙酰基)与摄入及新发心脏代谢多病相关。
核心结论
- 习惯性咖啡或咖啡因摄入,尤其是适量水平,与新发心脏代谢多病风险较低相关,并可能在心脏代谢多病发展的几乎所有转换阶段起重要作用。
研究设计与样本
- 前瞻性研究,纳入英国生物银行基线无任何心脏代谢疾病的172315名(咖啡因分析)和188091名(茶与咖啡分析)参与者,并在88204名和96393名参与者中测量168种代谢物。
- 心脏代谢多病定义为2型糖尿病、冠心病和卒中中至少2种共存。
主要发现
- 咖啡、茶和咖啡因摄入与新发心脏代谢多病风险呈非线性负相关。
- 与不消费或每日咖啡因摄入低于100毫克者相比,适量咖啡(3杯/天)者新发心脏代谢多病风险比0.519(95%CI 0.417-0.647),适量咖啡因(200-300毫克/天)者风险比0.593(95%CI 0.499-0.704)。
- 多状态模型显示,适量咖啡或咖啡因摄入与心脏代谢多病几乎所有发展阶段的转换风险呈负相关,包括从无病状态到单一心脏代谢疾病、再到心脏代谢多病的转换。
- 80至97种代谢物(如极低密度脂蛋白中的脂质成分、组氨酸和糖蛋白乙酰基)被识别为与咖啡、茶或咖啡因摄入及新发心脏代谢多病均相关。
局限性
- 未来研究需要验证咖啡、茶和咖啡因摄入与心脏代谢多病之间关系所涉及的代谢生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Cardiometabolic multimorbidity (CM) is an increasing public health concern. Previous observational studies have suggested inverse associations between coffee, tea, and caffeine intake and risks of individual cardiometabolic diseases; however, their associations with CM and related biological markers are unknown. METHODS: This prospective study involved 172 315 (for caffeine analysis) and 188 091 (tea and coffee analysis) participants free of any cardiometabolic diseases at baseline from the UK Biobank; 168 metabolites were measured among 88 204 and 96 393 participants. CM was defined as the coexistence of at least 2 of the following conditions: type 2 diabetes, coronary heart disease, and stroke. RESULTS: Nonlinear inverse associations of coffee, tea, and caffeine intake with the risk of new-onset CM were observed. Compared with nonconsumers or consumers of less than 100 mg caffeine per day, consumers of moderate amount of coffee (3 drinks/d) or caffeine (200-300 mg/d) had the lowest risk for new-onset CM, with respective hazard ratios (95% CIs) of 0.519 (0.417-0.647) and 0.593 (0.499-0.704). Multistate models revealed that moderate coffee or caffeine intake was inversely associated with risks of almost all developmental stages of CM, including transitions from a disease-free state to single cardiometabolic diseases and subsequently to CM. A total of 80 to 97 metabolites, such as lipid components within very low-density lipoprotein, histidine, and glycoprotein acetyls, were identified to be associated with both coffee, tea, or caffeine intake and incident CM. CONCLUSION: Habitual coffee or caffeine intake, especially at a moderate level, was associated with a lower risk of new-onset CM and could play important roles in almost all transition phases of CM development. Future studies are warranted to validate the implicated metabolic biomarkers underlying the relation between coffee, tea, and caffeine intake and CM.
引用
- Lu X, Zhu X, Li G, et al. Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity. J Clin Endocrinol Metab. 2025. PMID: 39287934. doi:10.1210/clinem/dgae552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。